We report the case of a 20 year old unmarried female patient who has been diagnosed as schizophrenia with intellectual disability. Patient was on chlorpromazine since last three years subsequently develop hyperprolactinemia, later manifested into fibrocystic breast disease. Hyperprolactinemia, is known for decades as neglected side effect of antipsychotic medication. Prolactin is secreted in a pulsatile manner by the anterior pituitary gland. The main physiological function of prolactin is to cause breast enlargement and galactorrhea initially and later develop to fibrocystic breast disease. Routine investigation also revealed hypothyroidism. Prolactin is known as immunomodulator, and has been linked to benign or malignant tumor growth.
INTRODUCTION
Hyperprolactinemia is a condition of elevated serum prolactin. Prolactin is a 198 amino acid protein produced in lactotroph cells of anterior pituitary glands. All conventional antipsychotics blocks D2 receptors on lactotroph cells and thus remove the main inhibitory influence on prolactin secretion. Elevation of prolactin levels occurs within a few hours of treatment initiation (1) . All antipsychotic causes significant changes in prolactin levels but some do increase prolactin above normal range at standard dosage. These drugs are chlorpromazine, risperidone, clozapine, olanzapine, and aripiprazole (2) (3) (4) . Persistent elevation of plasma prolactin is associated with number of adverse consequences; these includes sexual dysfunction (5), reduction in bone mineral density (6), breast enlargement and galactorrhea (7), suppression of hypothalamic pituitary gonadal axis (8) , and possible increase in the risk of breast cancer (3, 9, 10, 11) . Apart from hyperprolactinemia, other 
